Mega menu

Home
Product regulation
Product regulation

Understand your obligations and access industry Guidance and other information about the products we regulate.
Safety and shortages
Safety and shortages

Access information about product recalls, shortages and other alerts, and learn how we manage safety.
Resources and guidance
Resources and guidance

Get information to help you understand our work, regulations and industry obligations.
Business services
Business services

Access our systems to submit applications, manage forms, make payments and communicate securely.

AbbVie Pty Ltd

Regulatory activities for this sponsor.

- LinkedIn
- (Twitter)
- Facebook
- Email

Loading...

Type

ARTG (144)
Cancellation by sponsor (92)
Prescription medicine registration (27)
Australian public assessment report (AusPar) (22)
Designation or determination (7)
Prescription medicine evaluation (7)
Prescription medicine decision summary (2)
Section 14, TGO91 consent (1)

Date

2026 (14)
2025 (29)
2024 (26)
2023 (26)
2022 (12)
2021 (14)
2020 (20)
2019 (22)
2018 (14)
2017 (29)
2016 (5)
2015 (19)
2014 (26)
2013 (4)
2012 (4)
2011 (4)
2010 (4)
2009 (4)
2008 (3)
2007 (1)
2006 (4)
2005 (4)
2002 (2)
2001 (1)
1999 (1)
1998 (1)
1997 (1)
1996 (1)
1994 (2)
1991 (5)

Search

Sponsor content

302 result(s) found, displaying 251 to 260

BOTOX botulinum toxin type A purified neurotoxin complex 200U injection vial (172264)

2 March 2011

ARTG

Australian Register of Therapeutic Goods (ARTG) information for BOTOX botulinum toxin type A purified neurotoxin complex 200U injection vial.
CHIROCAINE levobupivacaine hydrochloride 125mg/200mL solution for injection bag Cancelled under s30(1)(c )

12 March 2015

Cancellation by sponsor

Requested by Abbvie Pty Ltd
Abbvie Pty Ltd - Adaptor Cancelled under s41GL(d)

13 October 2014

Cancellation by sponsor

Requested by Abbvie Pty Ltd
ALPHAGAN P 1.5 brimonidine tartrate 0.15% eye drop bottle (158888)

18 June 2010

ARTG

Australian Register of Therapeutic Goods (ARTG) information for ALPHAGAN P 1.5 brimonidine tartrate 0.15% eye drop bottle.
ENIDIN P 1.5 brimonidine tartrate 0.15% eye drop bottle (158893)

18 June 2010

ARTG

Australian Register of Therapeutic Goods (ARTG) information for ENIDIN P 1.5 brimonidine tartrate 0.15% eye drop bottle.
ZEMPLAR Injection paricalcitol 5 micrograms/1mL injection ampoule Cancelled under s30(1)(c )

3 September 2014

Cancellation by sponsor

Requested by Abbvie Pty Ltd
ZEMPLAR Capsules paricalcitol 1 microgram capsule blister pack Cancelled under s30(1)(c )

3 September 2014

Cancellation by sponsor

Requested by Abbvie Pty Ltd
ZEMPLAR Capsules paricalcitol 1 microgram capsule bottle Cancelled under s30(1)(c )

3 September 2014

Cancellation by sponsor

Requested by Abbvie Pty Ltd
ZEMPLAR paricalcitol 2 micrograms capsule blister pack Cancelled under s30(1)(c )

3 September 2014

Cancellation by sponsor

Requested by Abbvie Pty Ltd
ZEMPLAR Capsules paricalcitol 2 micrograms capsule bottle Cancelled under s30(1)(c )

3 September 2014

Cancellation by sponsor

Requested by Abbvie Pty Ltd

Pages

First page
Previous page
…
Page 22
Page 23
Page 24
Page 25
Current page 26
Page 27
Page 28
Page 29
Page 30
…
Next page
Last page

Using our website

Accessibility
Privacy
Security
Disclaimer
Copyright
Freedom of information
Acronyms and glossary terms

Quick links

Search our databases
Report a problem or side effect
TGA Business Services
Special Access Scheme
Authorised Prescriber
Office of Drug Control
State and territory contacts

Connect with us

Email subscriptions
Contact us
Facebook
(formerly Twitter)
Youtube
Instagram
LinkedIn

Help us improve

We are always looking for ways to improve our website.

Provide feedback

The Department of Health, Disability and Ageing acknowledges First Nations peoples as the Traditional Owners of Country throughout Australia, and their continuing connection to land, sea and community. We pay our respects to them and their cultures, and to all Elders both past and present.